Navigation Links
Tamiflu Fails To Save Two Lives

Two Vietnamese patients who were infected with the H5N1 bird flu died in spite of having been treated with the new Roche drug, Tamiflu. The virus appears to have developed a resistance // to the drug which is causing considerable concern among medical circles. The virus was seen to mutate in the patients, becoming more aggressive and killing the patients. The 274Y resistant strains were seen in both cases.

This has been reported by the British Wellcome Trust doctors to the New England Journal of Medicine. This calls for more antiviral drugs along with Tamiflu. This also means that taking low doses of the drug may prove to be dangerous as this will result in greater resistance to the drug and undermine its effects altogether. The UK Government alone has ordered for enough of the drug to cater to 25% of its population, with 3.5 million doses being delivered already.

The drug can still serve to reduce the severity of the attack of the virus. Instances of resistance to the drug has also been seen in Japan, especially in the case of children, adding to doubts with regard to the reliability of the drug which is being stockpiled across the world. The other drug which is available to counter the virus is the antiviral Relenza.

Page: 1

Related medicine news :

1. Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid
2. India To Procure 1 Million Doses Of Tamiflu
3. US Reviews Risks Of Tamiflu After 12 Children Die
4. US Regulator Sees No Link Between Tamiflu And Japan Deaths
5. Roche confirms Tamiflu production talks in US
6. Dosage Of Tamiflu Sought To Be Increased
7. Christmas trees to yield key Tamiflu ingredient
8. India to produce Tamiflu generic ‘Oseltamivir
9. A success for the Indian pharmacy: gets licence to manufacture Tamiflu
10. Hyderabad Firm To Manufacture Tamiflu In India
11. Tamiflu substrate produced from Bioengineered Bacteria
Post Your Comments:

(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... NJ (PRWEB) , ... October 13, 2017 , ... Global ... at scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global ... physical activity. The fun run is geared towards children of all ages; it ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: